Chad Messer
Stock Analyst at Lake Street
(0.16)
# 4,705
Out of 5,090 analysts
493
Total ratings
33.1%
Success rate
-4.8%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics | Initiated Coverage: Buy | $11 | $3.37 | +226.41% | 1 | Oct 28, 2026 | |
| ONCY Oncolytics Biotech | Reiterated: Buy | $5 | $0.4254 | +1,075.36% | 19 | Oct 14, 2026 | |
| CGEN Compugen | Reiterated: Buy | $6 | $1.98 | +203.03% | 5 | Oct 6, 2026 | |
| COYA Coya Therapeutics | Reiterated: Buy | $17 | $3.61 | +370.91% | 15 | Oct 6, 2026 | |
| CNSY Cerenome | Reiterated: Buy | $50 → $31 | $1.70 | +1,723.53% | 7 | Oct 1, 2026 | |
| OSTX OS Therapies | Reiterated: Buy | $13 | $1.24 | +948.39% | 20 | Sep 9, 2026 | |
| GNLX Genelux | Reiterated: Buy | $16 | $2.08 | +669.23% | 6 | Jun 30, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $103 | $70.32 | +46.47% | 7 | Jun 30, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $8.50 | +276.47% | 1 | Jun 11, 2026 | |
| IMNM Immunome | Reiterated: Buy | $30 | $18.21 | +64.74% | 9 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.6608 | +3,683.29% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $6.59 | +1,038.09% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.67 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $6.49 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $0.8944 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $5.70 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $5.56 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $69.13 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $62.99 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $6.31 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.7065 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.52 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $96.56 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $43.52 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.26 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.000001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $26.80 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $30 | $69.39 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.20 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $18.62 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.2895 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $30.55 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.24 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $27 | $16.03 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $6.83 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.000001 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $9.68 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.7027 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.24 | n/a | 1 | May 22, 2012 |
C4 Therapeutics
Oct 28, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.37
Upside: +226.41%
Oncolytics Biotech
Oct 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.4254
Upside: +1,075.36%
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $6
Current: $1.98
Upside: +203.03%
Coya Therapeutics
Oct 6, 2026
Reiterated: Buy
Price Target: $17
Current: $3.61
Upside: +370.91%
Cerenome
Oct 1, 2026
Reiterated: Buy
Price Target: $50 → $31
Current: $1.70
Upside: +1,723.53%
OS Therapies
Sep 9, 2026
Reiterated: Buy
Price Target: $13
Current: $1.24
Upside: +948.39%
Genelux
Jun 30, 2026
Reiterated: Buy
Price Target: $16
Current: $2.08
Upside: +669.23%
Monopar Therapeutics
Jun 30, 2026
Reiterated: Buy
Price Target: $103
Current: $70.32
Upside: +46.47%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $8.50
Upside: +276.47%
Immunome
Jun 1, 2026
Reiterated: Buy
Price Target: $30
Current: $18.21
Upside: +64.74%
May 18, 2026
Reiterated: Buy
Price Target: $25
Current: $0.6608
Upside: +3,683.29%
May 13, 2026
Reiterated: Buy
Price Target: $75
Current: $6.59
Upside: +1,038.09%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.67
Upside: -
Nov 1, 2021
Reiterated: Buy
Price Target: $6 → $7
Current: $6.49
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $0.8944
Upside: n/a
Aug 13, 2021
Reiterated: Buy
Price Target: $29
Current: $5.70
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $49
Current: $5.56
Upside: n/a
Aug 10, 2021
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $69.13
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $62.99
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $6.31
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $0.7065
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $1.52
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $96.56
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $43.52
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $40.26
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $26.80
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $33 → $30
Current: $69.39
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.20
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $18.62
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.2895
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $30.55
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $3.24
Upside: n/a
Apr 12, 2018
Reiterated: Buy
Price Target: $30 → $27
Current: $16.03
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $6.83
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Mar 6, 2015
Reiterated: Buy
Price Target: $7 → $4
Current: $9.68
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $0.7027
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $1.24
Upside: n/a